Antioxidant protection of LDL by physiological concentrations of 17β- estradiol: Requirement for estradiol modification

Circulation

Volumn 95, Issue 6, 1997, Pages 1378-1385

  Shwaery, Glenn T ^a   Vita, Joseph A ^a   Keaney Jr , John F ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

antioxidants; hormones; lipoproteins; women

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); ACYLTRANSFERASE; ALPHA TOCOPHEROL; CHOLESTEROL ESTER; COPPER ION; ESTRADIOL; ESTROGEN; LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOSE RESPONSE; ESTROGEN ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030894721     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.6.1378     Document Type: Article

References (11)

1. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
2. Kannel WB, Hjortland M, McNamara PM, Gordon T. Menopause and the risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85:447-452.
3. Stampfer JM, Colditz FA, Willett WC, Manson JE, Rosner B, Speizer F, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325:756-762.
4. Ettinger B, Friedman GD, Bush T, Quesenberry CP Jr. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 1996;87:6-12.
5. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
6. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J. 1988;115:954-963.
7. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1109.
8. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
9. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 1984;81: 3883-3887.
10. Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 1986;6: 505-510.
11. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest. 1984;74:1890-1894.